Oxford BioMedica
Adam Bird currently serves as the Senior Director of Quality Excellence at Oxford Biomedica, a position held since August 2011, with previous roles at the company including Director & Deputy Head of Quality and Acting Head of Quality. In addition to this role, Adam Bird is the Vice Chair of the Pharmaceutical & Healthcare Sciences Society since July 2016. Prior experience includes positions at ORBIS Consumer Products Limited, Boehringer Ingelheim, Hospira Aseptic Services Limited, Bupa Home Healthcare, Abbott Laboratories, Mitchells & Butlers, Pfizer, and GlaxoSmithKline. Adam Bird holds a postgraduate diploma in industrial pharmaceutical sciences from the University of Brighton and a degree in Biochemistry from the University of Kent.
This person is not in any teams
This person is not in any offices
Oxford BioMedica
2 followers
Oxford Biomedica (LSE: OXB) is a leading, fully integrated, cell and gene therapy group.